User:Chase Haven/Sandbox 1
From Proteopedia
| Line 34: | Line 34: | ||
=====D-D Interface===== | =====D-D Interface===== | ||
| - | One group analyzed their crystal structure of a fibrin D-Dimer that had been crosslinked by factor XIII. The junction between these two globular regions was not found to be tight; there were no salt bridges and minimal hydrogen bonding. In fact, there appeared to be a layer of solvent between them. This makes sense for the formation of a dynamic fibrin network; as too strong of an end to end interaction would make the clot too rigid. Also interesting about this particular crystal structure was the location of the gamma-gamma cross-link between the D regions: they weren’t visible. Density could not attribute these to a single location, meaning that the covalent bond between E396 and Q398 was highly mobile. This mobility was also observed by another group, who noted that there were several possible orientations in D-Dimer crystals. Taken altogether this provides evidence for the existence of weak interactions at the D-D interface that can slide around and “play,” potentially lending flexibility to the overall network.<ref>PMID: | + | One group analyzed their crystal structure of a fibrin D-Dimer that had been crosslinked by factor XIII. The junction between these two globular regions was not found to be tight; there were no salt bridges and minimal hydrogen bonding. In fact, there appeared to be a layer of solvent between them.<ref>PMID:9333233</ref> This makes sense for the formation of a dynamic fibrin network; as too strong of an end to end interaction would make the clot too rigid. Also interesting about this particular crystal structure was the location of the gamma-gamma cross-link between the D regions: they weren’t visible. Density could not attribute these to a single location, meaning that the covalent bond between E396 and Q398 was highly mobile. This mobility was also observed by another group, who noted that there were several possible orientations in D-Dimer crystals. Taken altogether this provides evidence for the existence of weak interactions at the D-D interface that can slide around and “play,” potentially lending flexibility to the overall network.<ref>PMID:9333233</ref><ref>PMID:20888119</ref> |
=====A:a Interaction===== | =====A:a Interaction===== | ||
Revision as of 19:10, 26 April 2014
Fibrinogen
Biological Role
The process of haemostasis is crucial to stemming blood loss following vascular injury. It involves a complex balance of pro- and anti-coagulant activities by a multitude of enzymes and cofactors that ultimately lead to a fibrin clot followed by attenuation of the coagulation response to restore normal blood flow. In short, the serine protease thrombin can be thought of as the star player: thrombin cleaves fibrinogen to fibrin (forming the clot) and also activates a trans-glutaminase (Factor XIII) which will create cross-links in the clot to enhance it's tensile strength. Furthermore, upon the formation of the clot thrombin also activates protein C as part of a negative feedback loop, which in turn degrades various cofactors and ultimately shuts down the coagulation response.[1]
Fibrinogen, the chief proteinaceous component of a clot, is a 340 kDa multidomain glycoprotein consisting of termed , and . It circulates in blood at concentrations generally ranging from 2 to 3 mg/mL.[2] Vascular injury exposes tissue factor-bearing subendothelial cells to flowing blood, triggering a coagulation response in order to generate thrombin. This serine protease has a unique specificity for cleavage sites on fibrinogen alpha and beta chains, and when cleaved fibrinopeptides A and B are released. This results in the exposure of polymerization sites known as "knobs", which are complementary to "holes" on other fibrinogen molecules. This interaction is non-covalent but strong enough to support the spontaneous growth of fibrin fibers and ultimately a fibrin clot network capable of stemming blood loss in vivo.[3]
Fibrin clots are highly heterogeneous; numerous factors play a role in determining fiber diameter, types of branch points, and number of branching fibers per unit area. Some of these factors are well understood, such as the effects of higher thrombin or fibrinogen concentrations. Others are less understood, such as calcium and metal ion levels, circulating lipid content, coagulation or fibrinolytic protein levels, some studies have even shown smoking and diabetes may change the structural layout or integrity of fibrin clots.[4]
| |||||||||||
References
- ↑ Mann KG, Brummel-Ziedins K, Orfeo T, Butenas S. Models of blood coagulation. Blood Cells Mol Dis. 2006 Mar-Apr;36(2):108-17. Epub 2006 Feb 23. PMID:16500122 doi:http://dx.doi.org/10.1016/j.bcmd.2005.12.034
- ↑ Kollman JM, Pandi L, Sawaya MR, Riley M, Doolittle RF. Crystal structure of human fibrinogen. Biochemistry. 2009 May 12;48(18):3877-86. PMID:19296670 doi:10.1021/bi802205g
- ↑ Falvo MR, Gorkun OV, Lord ST. The molecular origins of the mechanical properties of fibrin. Biophys Chem. 2010 Nov;152(1-3):15-20. doi: 10.1016/j.bpc.2010.08.009. PMID:20888119 doi:http://dx.doi.org/10.1016/j.bpc.2010.08.009
- ↑ Wolberg AS. Determinants of fibrin formation, structure, and function. Curr Opin Hematol. 2012 Sep;19(5):349-56. doi: 10.1097/MOH.0b013e32835673c2. PMID:22759629 doi:http://dx.doi.org/10.1097/MOH.0b013e32835673c2
- ↑ Kollman JM, Pandi L, Sawaya MR, Riley M, Doolittle RF. Crystal structure of human fibrinogen. Biochemistry. 2009 May 12;48(18):3877-86. PMID:19296670 doi:10.1021/bi802205g
- ↑ Kollman JM, Pandi L, Sawaya MR, Riley M, Doolittle RF. Crystal structure of human fibrinogen. Biochemistry. 2009 May 12;48(18):3877-86. PMID:19296670 doi:10.1021/bi802205g
- ↑ Kollman JM, Pandi L, Sawaya MR, Riley M, Doolittle RF. Crystal structure of human fibrinogen. Biochemistry. 2009 May 12;48(18):3877-86. PMID:19296670 doi:10.1021/bi802205g
- ↑ Cheng Y, LeGall T, Oldfield CJ, Dunker AK, Uversky VN. Abundance of intrinsic disorder in protein associated with cardiovascular disease. Biochemistry. 2006 Sep 5;45(35):10448-60. PMID:16939197 doi:http://dx.doi.org/10.1021/bi060981d
- ↑ Kollman JM, Pandi L, Sawaya MR, Riley M, Doolittle RF. Crystal structure of human fibrinogen. Biochemistry. 2009 May 12;48(18):3877-86. PMID:19296670 doi:10.1021/bi802205g
- ↑ Gallivan JP, Dougherty DA. Cation-pi interactions in structural biology. Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9459-64. PMID:10449714
- ↑ Zhang JZ, Redman CM. Role of interchain disulfide bonds on the assembly and secretion of human fibrinogen. J Biol Chem. 1994 Jan 7;269(1):652-8. PMID:8276866
- ↑ Kollman JM, Pandi L, Sawaya MR, Riley M, Doolittle RF. Crystal structure of human fibrinogen. Biochemistry. 2009 May 12;48(18):3877-86. PMID:19296670 doi:10.1021/bi802205g
- ↑ Zhang JZ, Redman CM. Role of interchain disulfide bonds on the assembly and secretion of human fibrinogen. J Biol Chem. 1994 Jan 7;269(1):652-8. PMID:8276866
- ↑ Falvo MR, Gorkun OV, Lord ST. The molecular origins of the mechanical properties of fibrin. Biophys Chem. 2010 Nov;152(1-3):15-20. doi: 10.1016/j.bpc.2010.08.009. PMID:20888119 doi:http://dx.doi.org/10.1016/j.bpc.2010.08.009
- ↑ Spraggon G, Everse SJ, Doolittle RF. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature. 1997 Oct 2;389(6650):455-62. PMID:9333233 doi:http://dx.doi.org/10.1038/38947
- ↑ Spraggon G, Everse SJ, Doolittle RF. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature. 1997 Oct 2;389(6650):455-62. PMID:9333233 doi:http://dx.doi.org/10.1038/38947
- ↑ Falvo MR, Gorkun OV, Lord ST. The molecular origins of the mechanical properties of fibrin. Biophys Chem. 2010 Nov;152(1-3):15-20. doi: 10.1016/j.bpc.2010.08.009. PMID:20888119 doi:http://dx.doi.org/10.1016/j.bpc.2010.08.009
- ↑ Falvo MR, Gorkun OV, Lord ST. The molecular origins of the mechanical properties of fibrin. Biophys Chem. 2010 Nov;152(1-3):15-20. doi: 10.1016/j.bpc.2010.08.009. PMID:20888119 doi:http://dx.doi.org/10.1016/j.bpc.2010.08.009
- ↑ Falvo MR, Gorkun OV, Lord ST. The molecular origins of the mechanical properties of fibrin. Biophys Chem. 2010 Nov;152(1-3):15-20. doi: 10.1016/j.bpc.2010.08.009. PMID:20888119 doi:http://dx.doi.org/10.1016/j.bpc.2010.08.009
- ↑ Collet JP, Moen JL, Veklich YI, Gorkun OV, Lord ST, Montalescot G, Weisel JW. The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis. Blood. 2005 Dec 1;106(12):3824-30. Epub 2005 Aug 9. PMID:16091450 doi:http://dx.doi.org/10.1182/blood-2005-05-2150
- ↑ Murakawa M, Okamura T, Kamura T, Shibuya T, Harada M, Niho Y. Diversity of primary structures of the carboxy-terminal regions of mammalian fibrinogen A alpha-chains. Characterization of the partial nucleotide and deduced amino acid sequences in five mammalian species; rhesus monkey, pig, dog, mouse and Syrian hamster. Thromb Haemost. 1993 Apr 1;69(4):351-60. PMID:8497848
- ↑ Doolittle RF, Kollman JM. Natively unfolded regions of the vertebrate fibrinogen molecule. Proteins. 2006 May 1;63(2):391-7. PMID:16288455 doi:http://dx.doi.org/10.1002/prot.20758
- ↑ Wang YZ, Patterson J, Gray JE, Yu C, Cottrell BA, Shimizu A, Graham D, Riley M, Doolittle RF. Complete sequence of the lamprey fibrinogen alpha chain. Biochemistry. 1989 Dec 12;28(25):9801-6. PMID:2611265
- ↑ Tatham AS, Shewry PR. Comparative structures and properties of elastic proteins. Philos Trans R Soc Lond B Biol Sci. 2002 Feb 28;357(1418):229-34. PMID:11911780 doi:http://dx.doi.org/10.1098/rstb.2001.1031
- ↑ Falvo MR, Millard D, O'Brien ET 3rd, Superfine R, Lord ST. Length of tandem repeats in fibrin's alphaC region correlates with fiber extensibility. J Thromb Haemost. 2008 Nov;6(11):1991-3. doi: 10.1111/j.1538-7836.2008.03147.x., Epub 2008 Aug 28. PMID:18761721 doi:http://dx.doi.org/10.1111/j.1538-7836.2008.03147.x
- ↑ Murakawa M, Okamura T, Kamura T, Shibuya T, Harada M, Niho Y. Diversity of primary structures of the carboxy-terminal regions of mammalian fibrinogen A alpha-chains. Characterization of the partial nucleotide and deduced amino acid sequences in five mammalian species; rhesus monkey, pig, dog, mouse and Syrian hamster. Thromb Haemost. 1993 Apr 1;69(4):351-60. PMID:8497848
- ↑ Stubbs MT, Oschkinat H, Mayr I, Huber R, Angliker H, Stone SR, Bode W. The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur J Biochem. 1992 May 15;206(1):187-95. PMID:1587268
- ↑ Stubbs MT, Oschkinat H, Mayr I, Huber R, Angliker H, Stone SR, Bode W. The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur J Biochem. 1992 May 15;206(1):187-95. PMID:1587268
- ↑ Stubbs MT, Oschkinat H, Mayr I, Huber R, Angliker H, Stone SR, Bode W. The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur J Biochem. 1992 May 15;206(1):187-95. PMID:1587268
- ↑ Mosesson MW, Siebenlist KR, Amrani DL, DiOrio JP. Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1113-7. PMID:2521950
- ↑ Stubbs MT, Oschkinat H, Mayr I, Huber R, Angliker H, Stone SR, Bode W. The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur J Biochem. 1992 May 15;206(1):187-95. PMID:1587268
